FDA — authorised 25 November 1996
- Application: NDA020690
- Marketing authorisation holder: EISAI INC
- Status: supplemented
🇺🇸 Aricept in United States
FDA authorised Aricept on 25 November 1996
Marketing authorisations
FDA — authorised 23 July 2010
- Application: NDA022568
- Marketing authorisation holder: EISAI INC
- Status: approved
FDA
- Status: approved
Aricept in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Aricept approved in United States?
Yes. FDA authorised it on 25 November 1996; FDA authorised it on 23 July 2010; FDA has authorised it.
Who is the marketing authorisation holder for Aricept in United States?
EISAI INC holds the US marketing authorisation.